International Pharmaceutical Expert Available to Speak on US-Canada Prescription Drug Controversy
IRVING, TX, 01/24/2005 -- Bryan Chance, CEO of Sigma Global Corporation (OTC: SGGC), a leader in the marketing of generic pharmaceuticals for chronic diseases, is available for comment on the current pending agreements between the Bush Administration and Canadian Prime Minister Paul Martin that would effectively eliminate the wildly popular practice of obtaining less expensive prescription drugs through Canadian pharmacies.
Due to the lower price that Canadians pay for prescription drugs as part of the nationalized healthcare system in Canada, hundreds of mail-order and Internet pharmacies have sprung up in the province of Manitoba, which in turn repackage drugs intended for Canadians and ship them to the US -- typically to patients where the prescribing doctor has never met the patient.
Anticipating this legislation, Sigma has worked with a number of Canadian pharmacies, including leading provider CanadaDrugs.com, to convert the millions of Americans now using Canadian pharmacies over to generic equivalents that will match or exceed the savings of the soon-to-be-outlawed Canadian program.
Chance, who also worked in management at such leading healthcare companies as Columbia/HCA and Price Waterhouse Coopers, says the demand for lower-priced prescription programs has been overwhelming, as has been the reaction of the current Canadian pharmacies looking for a place to find a legal home for their customers.
“We are amazed at the tremendous response we have received from other Canadian pharmacies that are ready to partner with us in preparation for the proposed legislative changes,” quipped Chance.
Bryan Chance will be available for commentary on this pending legislation. Please schedule interviews through Rita Tennyson at 310/821-6100x104 or firstname.lastname@example.org
About Sigma Global Corporation, Sigma Medical and SigmaRx -- Sigma Global Corporation is dedicated to providing innovative direct-to-consumer medical products and services, including a suite of integrated programs that help improve the process of long-term health maintenance for seniors and those suffering from chronic conditions. Sigma Medical/ SigmaRx operate a fully licensed pharmacy and distribution center that serves healthcare facilities, physicians and patients throughout North America. For more information on Sigma Global Corporation, Sigma Medical and SigmaRx, visit the company websites at www.sigmaglobalcorp.com, www.sigmamedical.com and www.sigmarx.com.
Statements that are not historical facts are forward-looking statements. The Company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors, factors that could cause actual results to differ materially from those estimated by the Company. They include, but are not limited to, government regulation, managing and maintaining growth, and the effect of adverse publicity, litigation, competition and other factors that may be identified from time to time in the Company’s public announcements.
- Contact Information
- Rita Tennyson
- Media Contact
- Terpin Communications Group
- Contact via E-mail
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.